Search Results - "Dassner, Aimee M."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Management of Pneumonia in the Pediatric Critical Care Unit: An Area for Antimicrobial Stewardship by Dassner, Aimee M, Nicolau, David P, Girotto, Jennifer E

    Published in Current pediatric reviews (01-02-2017)
    “…Pediatric pneumonia is one of the most common causes of childhood infection requiring hospitalization and is a substantial driver of antimicrobial use among…”
    Get more information
    Journal Article
  2. 2

    Safety and Tolerability of Monoclonal Antibody Therapies for Treatment of COVID-19 in Pediatric Patients by Mak, Gregory, Dassner, Aimee M., Hammer, Benjamin M., Hanisch, Benjamin R.

    Published in The Pediatric infectious disease journal (01-12-2021)
    “…There is a little data regarding safety or efficacy of monoclonal antibody treatment for mild-to-moderate COVID-19 in pediatric patients despite it being…”
    Get full text
    Journal Article
  3. 3

    One Size Fits All? Application of Susceptible-Dose-Dependent Breakpoints to Pediatric Patients and Laboratory Reporting by Nielsen, Lindsey E, Forrester, Jeanne B, Girotto, Jennifer Ellis, Dassner, Aimee M, Humphries, Romney

    Published in Journal of clinical microbiology (23-12-2019)
    “…The Clinical and Laboratory Standards Institute antimicrobial and antifungal standards define a susceptible-dose-dependent (SDD) category for certain organisms…”
    Get full text
    Journal Article
  4. 4

    Retrospective Observational Assessment of the Impact of Cefepime Prophylaxis in Neutropenic Pediatric Patients With Acute Myelogenous Leukemia by Almatrafi, Mohammed A, Dassner, Aimee M, Aquino, Victor, Slone, Tamra, Sebert, Michael

    “…Abstract Background The potential for cefepime prophylaxis to reduce bloodstream infections (BSIs) in pediatric patients with acute myelogenous leukemia (AML)…”
    Get full text
    Journal Article
  5. 5

    In vitro Activity of Ceftolozane/Tazobactam Alone or with an Aminoglycoside Against Multi-Drug-Resistant Pseudomonas aeruginosa from Pediatric Cystic Fibrosis Patients by Dassner, Aimee M., Sutherland, Christina, Girotto, Jennifer, Nicolau, David P.

    Published in Infectious diseases and therapy (01-03-2017)
    “…Introduction Gram-negative multi-drug resistance is an emerging threat among pediatric patients with cystic fibrosis (CF). Ceftolozane/tazobactam (C/T) is an…”
    Get full text
    Journal Article
  6. 6

    Evaluation of a Second-Sign Process for Antimicrobial Prior Authorization by Dassner, Aimee M, Girotto, Jennifer E

    “…A second-sign prospective restriction of select broad-spectrum antimicrobials was fully implemented in January 2015 as a pediatric antimicrobial stewardship…”
    Get full text
    Journal Article
  7. 7

    Impact of antimicrobial stewardship and rapid diagnostics in children with Staphylococcus aureus bacteremia by Welch, Stephanie N., Patel, Rupal M., Morris, Lee E., Dassner, Aimee M., Rozario, Nigel L., Forrester, Jeanne B.

    “…Introduction Rapid diagnostic testing (RDT) in combination with antimicrobial stewardship programs (ASPs) has been associated with improved outcomes in adults…”
    Get full text
    Journal Article